BR112012007877A2 - meios e métodos para produção de polissacarídeos capsulares artificiais de neisseria meningitidis - Google Patents

meios e métodos para produção de polissacarídeos capsulares artificiais de neisseria meningitidis

Info

Publication number
BR112012007877A2
BR112012007877A2 BR112012007877A BR112012007877A BR112012007877A2 BR 112012007877 A2 BR112012007877 A2 BR 112012007877A2 BR 112012007877 A BR112012007877 A BR 112012007877A BR 112012007877 A BR112012007877 A BR 112012007877A BR 112012007877 A2 BR112012007877 A2 BR 112012007877A2
Authority
BR
Brazil
Prior art keywords
capsular polysaccharides
neisseria meningitidis
methods
producing artificial
artificial capsular
Prior art date
Application number
BR112012007877A
Other languages
English (en)
Inventor
Bethe Andrea
Freiberger Friedrich
Stummeyer Katahrina
Mühlenhoff Martina
Gerardy-Schahn Rita
Damerow Sebastian
Original Assignee
Medizinische Hochschule Hannover
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizinische Hochschule Hannover filed Critical Medizinische Hochschule Hannover
Publication of BR112012007877A2 publication Critical patent/BR112012007877A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

Abstract

meios e métodos para produção de polissacarídeos capsulares artificiais de neisseria meningitidis. a invenção refere-se a um método in vitro para produção de polissacarídeos capsulares de neisseria meningitidis. a invenção também fornece polissacarídeos capsulares obteníveis pelos métodos descritos neste pedido. os polissacarídeos capsulares compreendem o polissacarídeo capsular específico para sorogrupos de neisseria meningitidis w-135, y, x e a.também são englobados polissacarídeos capsulares quiméricos compreendendo ou consistindo em cps de sorogrupos de neisseria meningitidis y /w-135, w-135/y, b/y, c/y, b/w-135, c/w-135, b/y/w-135, c/y/w-135, b/w-135/y, c/w-135/y, x/a ou a/x. a invenção também refere-se ao uso destes polissacarídeos capsulares como produtos farmacêuticos, particularmente como vacinas e/ou produtos diagnósticos.
BR112012007877A 2009-08-26 2010-08-26 meios e métodos para produção de polissacarídeos capsulares artificiais de neisseria meningitidis BR112012007877A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09168765 2009-08-26
PCT/EP2010/062481 WO2011023764A1 (en) 2009-08-26 2010-08-26 Means and methods for producing artificial capsular polysaccharides of neisseria meningitidis

Publications (1)

Publication Number Publication Date
BR112012007877A2 true BR112012007877A2 (pt) 2019-09-24

Family

ID=43086450

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012007877A BR112012007877A2 (pt) 2009-08-26 2010-08-26 meios e métodos para produção de polissacarídeos capsulares artificiais de neisseria meningitidis

Country Status (8)

Country Link
US (1) US20130012471A1 (pt)
EP (1) EP2470203A1 (pt)
CN (1) CN102596241A (pt)
BR (1) BR112012007877A2 (pt)
CA (1) CA2771672A1 (pt)
IN (1) IN2012DN01695A (pt)
RU (1) RU2012111424A (pt)
WO (1) WO2011023764A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014014067A (es) 2012-05-22 2015-02-04 Novartis Ag Conjugado de serogrupo x de meningococo.
WO2015158898A2 (en) 2014-04-17 2015-10-22 Medizinische Hochschule Hannover Means and methods for producing neisseria meningitidis capsular polysaccharides of low dispersity
EP3177325B1 (en) 2014-08-08 2020-04-01 GlaxoSmithKline Biologicals S.A. Modified host cells and hybrid oligosaccharides for use in bioconjugate production
MA40974B1 (fr) * 2014-11-18 2021-02-26 Pasteur Institut Anticorps polyclonaux spécifiques pour le sérogroupe x de n. Meningitidis et leurs utilisations dans le diagnostic
EP3316904A1 (en) * 2015-07-01 2018-05-09 GlaxoSmithKline Biologicals S.A. Immunogenic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
CA1223831A (en) 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
US5792608A (en) 1991-12-12 1998-08-11 Gilead Sciences, Inc. Nuclease stable and binding competent oligomers and methods for their use
US5525711A (en) 1994-05-18 1996-06-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pteridine nucleotide analogs as fluorescent DNA probes
CN1401774A (zh) * 2002-07-19 2003-03-12 大连理工大学 一种尿苷二磷酸葡萄糖焦磷酸化酶基因及其克隆

Also Published As

Publication number Publication date
IN2012DN01695A (pt) 2015-06-05
CA2771672A1 (en) 2011-03-03
RU2012111424A (ru) 2013-10-10
CN102596241A (zh) 2012-07-18
EP2470203A1 (en) 2012-07-04
WO2011023764A1 (en) 2011-03-03
US20130012471A1 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
BR112012007876A2 (pt) "membranas de troca de íons"
BR112017014258A2 (pt) anticorpos anti-cd47 e usos dos mesmos
IN2014DN09791A (pt)
WO2011098962A3 (fr) Polysaccharides anioniques fonctionnalisés par au moins deux groupements hydrophobes portés par un spacer au moins trivalent
MX371454B (es) Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos.
MX2013013111A (es) Composicion inmunogenica que presenta antigeno multiple, y metodos y usos de la misma.
BR112013030321A2 (pt) composição de vacina, método para preparar a composição de vacina, uso da composição de vacina, método para imunizar um porco, cepa de vacina contra csfv e uso de uma célula no cultivo de uma cepa de vacina contra csfv.
CL2012002195A1 (es) Composicion inmunogénica que comprende una mezcla de conjugados de polisacaridos-proteina multivalente que consiste en polisacáridos capsulares de streptococcus pneumoniae; metodo para inducir una respuesta inmune a un polisacarido capsular de streptococcus pneumoniae.
WO2012003377A3 (en) Methods of preparing chorion tissue and products derived therefrom
BR112017000596A2 (pt) micro-organismo geneticamente modificado, uso de um micro-organismo geneticamente modificado, e, método para preparar lacto-n-tetraose ou lacto-n-neotetraose ou um derivado fusosilado de lacto-n-tetraose ou lacto-n-neotetraose
MX364229B (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
BR112017005514A2 (pt) sacarídeos e composições e misturas de sacarídeo
MX350200B (es) Anticuerpos humanos y conjugados de anticuerpo-farmaco contra cd74.
MX347893B (es) Conjugados de farmaco y anticuerpo humano contra factor de tejido.
CO6690760A2 (es) Variantes no lipidadas de antígenos orf2086 de neisseria meningitidis
EP3380529B8 (en) Activated pectin-containing biomass compositions, products, and methods of producing
BR112014018815A8 (pt) Composição imunogênica compreendendo conjugado proteína-polissacarídeo x de n. meningitidis
BR112012007877A2 (pt) meios e métodos para produção de polissacarídeos capsulares artificiais de neisseria meningitidis
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
MX2022003706A (es) Anticuerpos anti-huntingtina (htt) derivados de humano y usos de los mismos.
WO2014060389A3 (en) Immunogenic composition
MX2018010920A (es) Nuevos conjugados de polisacarido-proteina, y procedimiento para obtener los mismos.
WO2015001013A3 (en) Human anti-ifn-alpha antibodies
GB201110777D0 (en) Methods and uses
BR112014020025A2 (pt) vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.